GATA-2 is an essential transcription factor in the hematopoietic system that is expressed in hematopoietic stem cells (HSCs) and progenitors. Complete deficiency of GATA-2 in the mouse leads to severe anemia and embryonic lethality. The role of GATA-2 and dosage effects of this transcription factor in HSC development within the embryo and adult are largely unexplored. Here we examined the effects of GATA-2 gene dosage on the generation and expansion of HSCs in several hematopoietic sites throughout mouse development. We show that a haploid dose of GATA-2 severely reduces production and expansion of HSCs specifically in the aorta-gonad-mesonephros region (which autonomously generates the first HSCs), whereas quantitative reduction of HSCs is minimal or unchanged in yolk sac, fetal liver, and adult bone marrow. However, HSCs in all these ontogenically distinct anatomical sites are qualitatively defective in serial or competitive transplantation assays. Also, cytotoxic drug-induced regeneration studies show a clear GATA-2 dose–related proliferation defect in adult bone marrow. Thus, GATA-2 plays at least two functionally distinct roles during ontogeny of HSCs: the production and expansion of HSCs in the aorta-gonad-mesonephros and the proliferation of HSCs in the adult bone marrow.
Skip Nav Destination
Article navigation
4 October 2004
Article|
October 04 2004
GATA-2 Plays Two Functionally Distinct Roles during the Ontogeny of Hematopoietic Stem Cells
Kam-Wing Ling,
Kam-Wing Ling
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
2Department of Immunology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Katrin Ottersbach,
Katrin Ottersbach
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Jan Piet van Hamburg,
Jan Piet van Hamburg
2Department of Immunology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Aneta Oziemlak,
Aneta Oziemlak
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Fong-Ying Tsai,
Fong-Ying Tsai
4Division of Hematology/Oncology, Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Stuart H. Orkin,
Stuart H. Orkin
4Division of Hematology/Oncology, Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Rob Ploemacher,
Rob Ploemacher
3Department of Hematology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Rudi W. Hendriks,
Rudi W. Hendriks
2Department of Immunology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Elaine Dzierzak
Elaine Dzierzak
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Search for other works by this author on:
Kam-Wing Ling
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
2Department of Immunology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Katrin Ottersbach
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Jan Piet van Hamburg
2Department of Immunology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Aneta Oziemlak
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Fong-Ying Tsai
4Division of Hematology/Oncology, Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115
Stuart H. Orkin
4Division of Hematology/Oncology, Children's Hospital and Dana Farber Cancer Institute, Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115
Rob Ploemacher
3Department of Hematology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Rudi W. Hendriks
2Department of Immunology, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Elaine Dzierzak
1Department of Cell Biology and Genetics, Erasmus University Medical Center, 3000 DR Rotterdam, Netherlands
Address correspondence to Elaine Dzierzak, Eramus University Medical Center, P.O. Box 1738, 3000 DR Rotterdam, Netherlands. Phone: 31-10-408-7172; Fax: 31-10-408-9468; email: [email protected]
Abbreviations used in this paper: AGM, aorta-gonads-mesonephros; CFU-GM, colony-forming unit–granulocyte macrophage; CFU-S11, colony-forming unit–spleen; E, embryonic day; ER, estrogen receptor; ES, embryonic stem; FL, fetal liver; 5-FU, 5-fluorouracil; GFP, green fluorescent protein; HSC, hematopoietic stem cell; LSK, Lin−Sca-1+c-kit+; YS, yolk sac.
Received:
September 09 2003
Accepted:
August 09 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (7): 871–882.
Article history
Received:
September 09 2003
Accepted:
August 09 2004
Citation
Kam-Wing Ling, Katrin Ottersbach, Jan Piet van Hamburg, Aneta Oziemlak, Fong-Ying Tsai, Stuart H. Orkin, Rob Ploemacher, Rudi W. Hendriks, Elaine Dzierzak; GATA-2 Plays Two Functionally Distinct Roles during the Ontogeny of Hematopoietic Stem Cells . J Exp Med 4 October 2004; 200 (7): 871–882. doi: https://doi.org/10.1084/jem.20031556
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement